Canariabio Inc

XKRX:016790 (Korea (the Republic of))   Ordinary Shares
â‚© 994.00 (0%) Jun 5
At Loss
Market Cap:
â‚© 185.87B ($ 135.44M)
Enterprise V:
â‚© 296.83B ($ 216.29M)
Volume:
-
Avg Vol (2M):
-

Business Description

Description
Canariabio Inc is a biotechnology company specializing in the development of new anticancer drugs and has research assets for the development of immunotherapy drugs. Through its subsidiaries, the company has a pipeline for the development of various immunotherapy drugs for ovarian cancer, pancreatic cancer, and metastatic breast cancer.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.04
Equity-to-Asset -0.47
Debt-to-Equity -2.06
Debt-to-EBITDA -0.58
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -10.17
Distress
Grey
Safe
Beneish M-Score -11.78
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -4.5
Name Current Vs Industry Vs History
5-Day RSI 28.63
9-Day RSI 22.48
14-Day RSI 22.03
6-1 Month Momentum % -81.21
12-1 Month Momentum % -90.98

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.36
Quick Ratio 0.28
Cash Ratio 0.03
Days Inventory 43.42
Days Sales Outstanding 78.41
Days Payable 17.37

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -26.6
Shareholder Yield % -14.09
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Canariabio Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil â‚©) 152,209.671
EPS (TTM) (â‚©) -1381.667
Beta 1.9
Volatility % 79.63
14-Day RSI 22.03
14-Day ATR (â‚©) 1.038088
20-Day SMA (â‚©) 994
12-1 Month Momentum % -90.98
52-Week Range (â‚©) 899 - 10816.666666
Shares Outstanding (Mil) 186.99

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Canariabio Inc Filings

Filing Date Document Date Form
No Filing Data

Canariabio Inc Stock Events

Financials Calendars
Event Date Price(â‚©)
No Event Data

Canariabio Inc Frequently Asked Questions

What is Canariabio Inc(XKRX:016790)'s stock price today?
The current price of XKRX:016790 is â‚©994.00. The 52 week high of XKRX:016790 is â‚©10816.67 and 52 week low is â‚©899.00.
When is next earnings date of Canariabio Inc(XKRX:016790)?
The next earnings date of Canariabio Inc(XKRX:016790) is .
Does Canariabio Inc(XKRX:016790) pay dividends? If so, how much?
Canariabio Inc(XKRX:016790) does not pay dividend.

Press Release

Subject Date
No Press Release